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For nearly a century, neuroscientists have sought to restore neurological function across spinal
cord lesions. Lu et al. now present significant progress toward this goal, showing in rats that trans-
planted neural stem cells establish a functional bridge across completely transected spinal cords.Spinal cord injury (SCI) in adult mammals
causes large zones of necrosis to develop
at the site of injury, creating gaps or voids
that prevent communication between
brain and spinal cord. Axons cannot cross
this gap; any attempt at regeneration is
met with failure as axons either retract
from the injury site or linger near the lesion
borders. Scientists have long believed
that intraspinal transplants can be used
as bridges or functional relays capable
of restoring communication across the
injury site. Successful graft integration
and subsequent growth of axons into or
out of the transplant depends on several
factors, including lesion size, time to
transplantation (acute versus chronic),
source of transplant (that is, neurons,
Schwann cells, olfactory ensheathing
glia, or bone marrow stromal cells), devel-
opmental stage of transplanted cells,
presence of supportive matrices, use of
adjunct therapies (such as growth factors
or immunosuppressants), genetic match-
ing, and manipulation of the glial scar
(for example, by treatment with chondroi-
tinase) (Reier, 2004). Until now, such ap-
proaches have met with limited success.
In this issue of Cell, Lu et al. (2012b)
show in rats that it is possible to dramati-
cally improve the survival, growth, and
integration of neural transplants and to
functionally bridge a complete spinal
resection lesion (2 mm gap), a formidable
preclinical SCI injury model, by using
suspensions of embryonic rat or human
neural stem cells (NSCs). In all cases,
transplanted cells are engineered to
express enhanced green fluorescent
protein (EGFP), allowing unprecedented
visualization of cellular growth and con-
nectivity. Their data show that thousands
of graft-derived axons grow effortlesslyinto host white and gray matter at rates
comparable to regenerating peripheral
axons (1–2 mm/day) and can promote
recovery of hindlimb function. Notably,
these effects are achieved without
creating neurotrophic gradients or dis-
solving the glial scar.
Several laboratories have documented
anatomical and functional repair in the
injured spinal cord by using various trans-
plantation techniques (Sahni and Kessler,
2010); however, the current report docu-
ments what is, to date, the most robust
example of transplant-mediated repair in
the central nervous system. It is likely
that the success of Lu et al. (2012b)
can be traced to techniques used to
suspend and deliver cells to the injured
spinal cord. Specifically, NSCs are bathed
in a cocktail of proliferative and neurotro-
phic factors mixed into a fibrin gel
(Figure 1). When injected into the injury
site, this ‘‘perfect storm’’ of proteins and
matrix provide sustained trophic support
and a protective niche from which thou-
sands of graft-derived axons projected
up to 25 mm between the cervical or
lumbar spinal cord. Moreover, the trans-
plants were electrically active, acting
as relay networks capable of restoring
partial function in paralyzed hindlimbs
of rats.
Other functional modalities have not
been tested, but it is logical to question
the broader neurological impact of these
transplants. For example, graft-derived
choline acetyltransferase (ChAT)-positive
axons extend into ventral roots adjacent
to the transplantation site. If these axons
form functional neuromuscular junctions
with skeletal muscle, a difficult task and
one that likely requires concomitant
trophic cues in the periphery (DeshpandeCell 150, Sepet al., 2006), the newly established seg-
mental circuitry might be useful for
controlling axial musculature, sphincter
control, or improving breathing. It also
would be useful to know whether the
transplants can alleviate spasticity,
neuropathic pain, or autonomic dysre-
flexia—that is, aberrant functional
changes caused by segmental plasticity
below the level of injury. Of course, robust
growth and new circuit formation could
have the opposite effect of exacerbating
pain, spasticity, or autonomic dysreflexia
(Brown and Weaver, 2012). Lu et al.
(2012a) recently reported that promoting
robust axonal regeneration beyond the
site of SCI can enhance spasticity that
subverts motor recovery.
In the current report, the authors
consider possible molecular mechanisms
underlying the robust growth of trans-
planted NSC axons. In a recent landmark
paper, the tumor suppressor gene Pten
was identified as a negative regulator
of mTOR-dependent axon growth in
the adult spinal cord (Liu et al., 2010).
Here, Lu et al. (2012b) show that axonal
outgrowth was reduced by 50% in
rats injected with the mTOR inhibitor
rapamycin, suggesting that early-stage
neurons use mTOR-dependent mecha-
nisms to overcome barriers to axon
growth after SCI. However, thousands
of axons still extended several millime-
ters beyond the site of transplantation
in rats injected with rapamycin, sug-
gesting that mTOR-independent mecha-
nisms also contribute to this remarkable
growth.
Confirming previous data (Josephson
et al., 2002), Lu et al. (2012b) find that
transplanted embryonic NSCs express
mRNA encoding receptors for Nogo,tember 14, 2012 ª2012 Elsevier Inc. 1105
Figure 1. Neural Stem Cell Transplantation for the Repair of Spinal
Cord Injury
The schematic illustrates the approach used by Lu et al. (2012b) for promoting
repair following spinal cord injury. At 14 days postinjury, a cocktail of growth
factors (listed in the pop-out of the gel/cell suspension), a calpain inhibitor, and
rat or human embryonic spinal cord neural stem cells (NSCs) are suspended in
a fibrin gel, which is then injected into rats with a complete spinal transection
(with resection) lesion, filling a gap of2mm. After 7 weeks, a subset of grafted
NSCs (green) differentiated into neurons (30% of grafted cells), which pro-
jected axons over multiple spinal segments, bridging cervical and lumbar
spinal cord. Host-derived axons (gray) grow into the transplant and form
synapses. Only supraspinal (reticulospinal) host axons were traced. NT-3,
neurotrophin-3; BDNF, brain-derived neurotrophic factor; EGF, epidermal
growth factor; GDNF, glial-cell-line-derived neurotrophic factor; bFGF, basic
fibroblast growth factor; aFGF, acidic fibroblast growth factor; PDGF-AA,
platelet-derived growth factor; HGF, hepatocyte growth factor; IGF-1, insulin-
like growth factor-1.amyelin inhibitory protein that
causes axonal growth cone
collapse. From these data,
they conclude that insensi-
tivity to myelin-based inhibi-
tors cannot account for the
robust axon growth that they
observe. Taken alone, their
data suggest that there is
hierarchical control of mam-
malian CNS axon regenera-
tion, with neuron-intrinsic
regulation trumping the
effects of extrinsic factors.
However, Itzhak Fischer’s
group recently discovered
that NSCs express lower
levels of the receptors protein
tyrosine phosphatase sigma
(PTPs) and leukocyte com-
mon antigen-related phos-
phatase (LAR), rendering
NSCs less sensitive to the
growth inhibitory effects of
chondroitin sulfate proteogly-
cans (CSPGs) (Ketschek
et al., 2012). The same group
also showed that glial-
restricted precursors (derived
from embryonic spinal cord
cells of similar age to those
used in the present study)
secrete unknown factors that
augment axonal outgrowth
across CSPG gradients (Ket-
schek et al., 2012). Whether
NPC-derived glia, whichaccount for 45% of differentiated cells
in the NSC transplants of Lu et al.
(2012b), are integral in promoting axonal
outgrowth is not determined in the present
study.
The magnitude of axonal growth and
functional recovery achieved in this
report is truly unprecedented, and there
is little doubt that these data will prompt1106 Cell 150, September 14, 2012 ª2012 Elexcitement about the clinical potential of
treating SCI with NSC transplants.
However, from both a biological and
translational perspective, it will be impor-
tant to first test whether similar benefits
can be achieved in models of spinal
contusion injury. Unlike the resection
model used here, axons are spared at
the site of most human spinal injuries,sevier Inc.and residual neurological
function is not uncommon.
This reality will prompt the
inevitable debate of whether
transplantation, an invasive
procedure, will do more
harm than good. While that
debate rages on, we can
and should revel in the fact
that these new data show
that it is possible to rebuild
the spinal cord or at least
partially repair it.REFERENCES
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